Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Aura Biosciences, Inc. per 2025 Jun 30 adalah -108.69 MM.
- Nilai net income untuk Aura Biosciences, Inc. per 2025 Jun 30 adalah -101.38 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -108.69 | -101.38 | |
2025-03-31 | -102.84 | -94.70 | |
2024-12-31 | -96.12 | -86.92 | |
2024-09-30 | -93.09 | -83.22 | |
2024-06-30 | -90.35 | -80.69 | |
2024-03-31 | -87.86 | -78.65 | |
2023-12-31 | -84.99 | -76.41 | |
2023-09-30 | -77.82 | -70.84 | |
2023-06-30 | -73.39 | -68.22 | |
2023-03-31 | -66.93 | -63.39 | |
2022-12-31 | -60.30 | -58.76 | |
2022-09-30 | -54.31 | -53.84 | |
2022-06-30 | -47.15 | -46.77 | |
2022-03-31 | -42.13 | -42.16 | |
2021-12-31 | -35.25 | -35.25 | |
2021-09-30 | -28.53 | -28.52 | |
2021-06-30 | -23.27 | -23.32 | |
2021-03-31 | -20.62 | -20.62 | |
2020-12-31 | -22.21 | -22.21 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -1.90 | -1.90 |
2024-12-31 | -1.75 | |
2024-09-30 | -1.72 | -1.72 |
2024-06-30 | -1.77 | -1.77 |
2024-03-31 | -1.85 | -1.85 |
2023-12-31 | -1.93 | |
2023-09-30 | -1.94 | -1.94 |
2023-06-30 | -1.99 | -1.99 |
2023-03-31 | -1.98 | -1.98 |
2022-12-31 | -1.96 | |
2022-09-30 | -2.06 | -2.06 |
2022-06-30 | -2.65 | -2.65 |
2022-03-31 | -4.11 | -4.11 |
2021-12-31 | -8.95 | |
2021-09-30 | -97.02 | -97.02 |
2021-06-30 | -83.60 | -83.60 |
2021-03-31 | -76.03 | -76.03 |
2020-12-31 | -82.06 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Aura Biosciences, Inc. per 2025 Jun 30 adalah -83.35 MM.
- Nilai cash from investing activities untuk Aura Biosciences, Inc. per 2025 Jun 30 adalah 89.37 MM.
- Nilai kas dari aktivitas pendanaan untuk Aura Biosciences, Inc. per 2025 Jun 30 adalah 71.28 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -83.35 | 89.37 | 71.28 |
2025-03-31 | -78.71 | 89.24 | 1.44 |
2024-12-31 | -79.81 | 68.82 | 1.59 |
2024-09-30 | -73.24 | -50.99 | 94.04 |
2024-06-30 | -73.37 | -39.25 | 94.95 |
2024-03-31 | -71.89 | -37.69 | 97.34 |
2023-12-31 | -63.85 | -113.96 | 97.29 |
2023-09-30 | -64.47 | -40.72 | 99.50 |
2023-06-30 | -59.83 | -44.40 | 97.98 |
2023-03-31 | -55.81 | -109.25 | 95.81 |
2022-12-31 | -54.60 | -67.87 | 95.63 |
2022-09-30 | -48.67 | -51.81 | 80.57 |
2022-06-30 | -46.60 | -70.33 | 79.35 |
2022-03-31 | -42.47 | -27.55 | 78.79 |
2021-12-31 | -32.41 | -2.12 | 166.26 |
2021-09-30 | -24.08 | -1.44 | 91.25 |
2021-06-30 | -22.00 | -0.97 | 97.17 |
2021-03-31 | -21.37 | -0.36 | 97.51 |
2020-12-31 | -24.32 | -0.77 | 10.04 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Aura Biosciences, Inc. pada 2025 Jun 30 adalah -3.32.
- p/libro untuk Aura Biosciences, Inc. pada 2025 Jun 30 adalah 2.46.
- p/tbv untuk Aura Biosciences, Inc. pada 2025 Jun 30 adalah 2.46.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -3.32 | 2.46 | 2.46 |
2025-03-31 | 2.10 | 2.10 | |
2024-12-31 | 2.33 | 2.33 | |
2024-09-30 | -5.55 | 2.34 | 2.34 |
2024-06-30 | -4.74 | 1.79 | 1.79 |
2024-03-31 | 1.68 | 1.68 | |
2023-12-31 | -6.17 | 2.88 | 2.88 |
2023-09-30 | -5.12 | 2.10 | 2.10 |
2023-06-30 | -7.37 | 2.59 | 2.59 |
2023-03-31 | -5.94 | 1.79 | |
2022-12-31 | 3.37 | 3.37 | |
2022-09-30 | 4.11 | 4.11 | |
2022-06-30 | -9.83 | 2.94 | 2.94 |
2022-03-31 | -18.11 | 4.19 | 4.19 |
2021-12-31 | -17.52 | 5.93 | 5.93 |
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Aura Biosciences, Inc. pada 2025 Jun 30 adalah -0.34.
- EBIT (3 tahun) / EV untuk Aura Biosciences, Inc. pada 2025 Jun 30 adalah -0.29.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.34 | -0.29 |
2025-03-31 | -0.30 | -0.27 |
2024-12-31 | -0.22 | -0.19 |
2024-09-30 | -0.19 | -0.16 |
2024-06-30 | -0.23 | -0.18 |
2024-03-31 | -0.23 | -0.17 |
2023-12-31 | -0.19 | -0.13 |
2023-09-30 | -0.23 | -0.15 |
2023-06-30 | -0.15 | -0.10 |
2023-03-31 | -0.26 | -0.18 |
2022-12-31 | -0.16 | -0.08 |
2022-09-30 | -0.10 | -0.05 |
2022-06-30 | -0.14 | -0.10 |
2022-03-31 | -0.07 | -0.05 |
2021-12-31 | -0.05 | -0.04 |
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 |
Efektivitas Manajemen
- roa untuk Aura Biosciences, Inc. pada 2025 Jun 30 adalah -0.43.
- roe untuk Aura Biosciences, Inc. pada 2025 Jun 30 adalah -0.49.
- roic untuk Aura Biosciences, Inc. pada 2025 Jun 30 adalah -0.65.
- croic untuk Aura Biosciences, Inc. pada 2025 Jun 30 adalah 0.08.
- ocroic untuk Aura Biosciences, Inc. pada 2025 Jun 30 adalah -0.54.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.43 | -0.49 | -0.65 | 0.08 | -0.54 |
2025-03-31 | -0.37 | -0.42 | -0.51 | -0.05 | -0.47 |
2024-12-31 | -0.33 | -0.37 | -0.43 | -0.16 | -0.38 |
2024-09-30 | -0.45 | -0.53 | -0.38 | -0.08 | -0.35 |
2024-06-30 | -0.38 | -0.44 | -0.34 | -0.05 | -0.32 |
2024-03-31 | -0.34 | -0.39 | -0.31 | -0.33 | -0.26 |
2023-12-31 | -0.49 | -0.62 | -0.41 | -0.03 | -0.38 |
2023-09-30 | -0.51 | -0.53 | -0.37 | -0.03 | -0.32 |
2023-06-30 | -0.47 | -0.49 | -0.37 | -0.03 | -0.32 |
2023-03-31 | -0.40 | -0.42 | -0.32 | -0.34 | -0.28 |
2022-12-31 | -0.59 | -0.64 | -0.40 | -0.15 | -0.36 |
2022-09-30 | -0.52 | -0.55 | -0.40 | -0.15 | -0.36 |
2022-06-30 | -0.43 | -0.46 | -0.36 | -0.29 | -0.36 |
2022-03-31 | -0.34 | -0.35 | -0.30 | 0.06 | -0.30 |
2021-12-31 | -1.29 | -1.47 | -0.23 | 0.86 | -0.28 |
2021-09-30 | -1.29 | -1.47 | -0.33 | 0.77 | -0.28 |
2021-06-30 | -0.63 | -0.76 | -0.25 | 0.79 | -0.23 |
2021-03-31 | -0.56 | -0.67 | -0.20 | 0.74 | -0.21 |
2020-12-31 | -0.60 | -0.72 | -1.15 | -0.78 | -1.26 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1501796 |
Grupong Pang-industriya
SIC 2836 - Biological Products, Except Diagnostic Substances (Biotech) |